Fatty liver disease by ultrasound: prevalence and associations with cardiometabolic risk factors in a siberian population

   Purpose: we aimed to study the prevalence of sonographic pattern of fatty liver disease (FLD) and its associations with cardiometabolic risk factors depending on sex.

   Subject and methods. We used data from the WHO MONICA Project in Novosibirsk, Russia. Fatty liver disease was studied by echography in a random population sub-sample (n = 2025 and aged 25–64 years). The association of FLD with potential determinants was estimated in logistic regression. Results. The prevalence of fatty liver disease was 20 % in men and 19 % in women. In men, its multivariable-adjusted predictors included age, body mass index (BMI), level of triglycerides and frequency of alcohol drinking or high occasional dose (≥ 120 g of ethanol). In women, in age-adjusted model we have revealed the association between FLD and BMI, level of total cholesterol, HDL-cholesterol and triglycerides, and diabetes mellitus. In multivariable-adjusted model only the association between FLD and BMI remained significant.

   Conclusion. The prevalence of sonographic pattern of FLD is similar among Siberian men and women (20 and 19 %, correspondently). These data are consistent with data from European, North American and Asian populations. In men, 6.2 % of FLD was attributable to alcohol, 6.2 % – non-alcoholic FLD and 7.8 % to other conditions. In women, two-thirds of cases were NAFLD and one-third was accounted for other causes. In category of other causes – 72 % (women) and 93 % (men) of participants were carriers of markers of virus hepatitis. In men, the determinants of FLD were frequent alcohol intake, triglycerides level, and BMI. In women, BMI was the most significant independent predictor of FLD.

1. Hamer O. W., Aguirre D. A., Casola G., Lavine J. E., Woenckhaus M., Sirlin C. B. Fatty Liver: Imaging Patterns and Pitfalls // Radio Graphics. 2006. Vol. 26. P. 1637–1653.

2. Harrison S.A., Torgerson S., Hayashi P.H. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study // Am. J. Gastroenterol. 2003. Vol. 98. P. 2042–2047 (Abstract).

3. Davies R. J., Saverymuttu S. H., Fallowfield M., Joseph A. E. Paradoxal lack of ultrasound attenuation with gross fatty change in the liver // Clin. Radiol. 1991. Vol. 43. P. 393–396. (Abstract).

4. Angulo P., Bellentani S., Saccoccio G., Masutti F., Crocи L.S., Brandi G. et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy // Ann. Intern. Med. 2000. Vol. 132. P. 112–117.

5. Boza C., Riquelme A., Ibanez L., Duarte I., Norero E., Viviani P. et al. Predictors of nonalcoholic steatohepatosis in obese patients undergoing gastric bypass // Obes. Surg. 2005. Vol. 15. P. 1148–1153.

6. Dixon J. B., Bhathal P. S., O’Brien P. E. Non-alcoholic fatty liver diseases: predictors of non- alcoholic steatohepatosis and liver fibrosis in the severe obese // Gastroenterology. 2001. Vol. 121. P. 91–100.

7. Kurilovich S. A., Reshetnikov O. V., Rybiakov A. N., Shakhmatov S. G., Malytina S. K., Ivanova M. V. Diffuse liver lesions among the general population of Western Siberia // Int. J. Circumpolar. Health. 2001. Apr; Vol. 60 (2). P. 264–267.

8. MONICA Monograph and Multimedia Sourcebook / H. Tunstall-Pedoe (ed). Prepared by H. Tunstall-Pedoe, K. Kuulasmaa, H. Tolonen, M. Davidson, S. Men dis with 64 other contributors for The WHO MONICA Project. MONICA Monograph and MultimediaSourcebook. Geneva: World Health Organization; 2003.

9. Sanyal A. J. AGA Technical review on non-alcoholic fatty liver diseases // Gastroenterology. 2002. Vol. 123. P. 1705–1725.

10. Bland J. M., Altman D. G. Statistical methods for assessing agreement between two methods of clinical measurement // Lancet. 1986. Vol. 1. P. 307–310.

11. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus // Diab. Care. 2003. Vol. 26 (Suppl I). P. S5–S20.

12. Malyutina S., Bobak M., Kurilovitch S., Gafarov V., Simonova G., Nikitin Yu., Marmot M. Relation between heavy and all-cause and cardiovascular mortality in Novosibirsk, Russia: a prospective cohort study // Lancet. 2002. Vol. 360. P. 1448–1454.

13. Bobak M., Room R., Pikhart H., Kubinova R., Malyutina S., Pajak A., Kurilovitch S., Topor R., Nikitin Y., Marmot M. Contribution of drinking patterns to differences in rates of alcohol related problems between three urban populations // J. Epidemiol. Community. Health. 2004. Vol. 58. P. 238–242.

14. Scaglioni F., Ciccia S., Marino M., Bedogni G., Bellentani S. ASH and NASH // Dig. Dis. 2011. Vol. 29. P. 202–210.

15. Schwimmer J. B., McGreal N., Deutsch R., Finegold M. J., Lavine J. E. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents // Pediatrics. 2005. Vol. 115. P. 561–5. (Abstract).

16. Weston S. R., Leyden W., Murphy R. et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease // Hepatology. 2005. Vol. 41. P. 372–379. (Abstract).

17. Bellentani S., Scaglioli F., Marino M., Bedogni G. Epidemiology of non–alcoholic fatty liver disease // Dig. Dis. 2010. Vol. 28. P. 155–161.

18. Bhatia L. C., Curzen N. P., Calder P. C., Byrne C. D. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? // Eur. Heart J. 2012. Vol. 33. P. 1190–1200.

19. Hart C. L., Morrison D. S., Batty G. D., Mitchel R. J., Smith G. D. Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies // BMJ. 2010. Vol. 340. P. 1240–1247.